VIVIAN C MENCHACA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family DALLAS, TX NPI 1427010073

General Payments — all program years on this page

$1,626.55

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 62
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $521.23 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $521.2316

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $214.234
Amgen Inc. $209.187
PFIZER INC. $44.872
Paratek Pharmaceuticals, Inc. $20.961
GlaxoSmithKline, LLC. $17.631
Merck Sharp & Dohme Corporation $14.361

By program year

Program yearAmountRecords
2021 $241.5515
2022 $189.8512
2023 $673.9219
2024 $521.2316

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104238065 AstraZeneca Pharmaceuticals LP $67.13 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105609671 AstraZeneca Pharmaceuticals LP $115.43 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105744536 AstraZeneca Pharmaceuticals LP $15.21 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105865762 AstraZeneca Pharmaceuticals LP $16.46 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113931480 Paratek Pharmaceuticals, Inc. $20.96 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116624653 GlaxoSmithKline, LLC. $17.63 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117326513 Amgen Inc. $124.82 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117628122 Amgen Inc. $20.79 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117628124 Amgen Inc. $18.34 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117628126 Amgen Inc. $21.17 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117628128 Amgen Inc. $4.67 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117628130 Amgen Inc. $9.14 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117628132 Amgen Inc. $10.25 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132006110 PFIZER INC. $22.81 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132012876 PFIZER INC. $22.06 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141963543 Merck Sharp & Dohme LLC $14.36 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.